232 related articles for article (PubMed ID: 23879627)
61. Generation of stable suspension producer cell lines for serum-free lentivirus production.
Klimpel M; Terrao M; Bräuer M; Dersch H; Biserni M; Melo Do Nascimento L; Schwingal S; Vogel JE; Ferlemann C; Brandt T; Lal NI; Bridgeman K; Petzke A; McDwyer E; Lim JL; Oh S; Brumatti G; Garcia Minambres A; Otte E; Noll T; Pirzas V; Laux H
Biotechnol J; 2024 May; 19(5):e2400090. PubMed ID: 38719592
[TBL] [Abstract][Full Text] [Related]
62. Generation of a new Gateway-compatible inducible lentiviral vector platform allowing easy derivation of co-transduced cells.
De Groote P; Grootjans S; Lippens S; Eichperger C; Leurs K; Kahr I; Tanghe G; Bruggeman I; De Schamphelaire W; Urwyler C; Vandenabeele P; Haustraete J; Declercq W
Biotechniques; 2016; 60(5):252-9. PubMed ID: 27177818
[TBL] [Abstract][Full Text] [Related]
63. [Establishment of a high expressing system of human coagulant factor VIII in vitro].
Cheng H; Xu KL; Sun HY; Lu QX; He XP; Pan XY
Zhonghua Xue Ye Xue Za Zhi; 2009 Mar; 30(3):166-70. PubMed ID: 19642364
[TBL] [Abstract][Full Text] [Related]
64. Efficiency of promoter and cell line in high-level expression of erythropoietin.
Park JH; Kim C; Kim WB; Kim YK; Lee SY; Yang JM
Biotechnol Appl Biochem; 2000 Dec; 32(3):167-72. PubMed ID: 11115388
[TBL] [Abstract][Full Text] [Related]
65. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells.
Fan L; Kadura I; Krebs LE; Hatfield CC; Shaw MM; Frye CC
Biotechnol Bioeng; 2012 Apr; 109(4):1007-15. PubMed ID: 22068567
[TBL] [Abstract][Full Text] [Related]
66. Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping.
Ni W; Le Guiner C; Gernoux G; Penaud-Budloo M; Moullier P; Snyder RO
Gene Ther; 2011 Jul; 18(7):709-18. PubMed ID: 21390073
[TBL] [Abstract][Full Text] [Related]
67. Lentivirus Production and Purification.
Benskey MJ; Manfredsson FP
Methods Mol Biol; 2016; 1382():107-14. PubMed ID: 26611582
[TBL] [Abstract][Full Text] [Related]
68. Using matrix attachment regions to improve recombinant protein production.
Harraghy N; Buceta M; Regamey A; Girod PA; Mermod N
Methods Mol Biol; 2012; 801():93-110. PubMed ID: 21987249
[TBL] [Abstract][Full Text] [Related]
69. Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells.
Gama-Norton L; Botezatu L; Herrmann S; Schweizer M; Alves PM; Hauser H; Wirth D
Hum Gene Ther; 2011 Oct; 22(10):1269-79. PubMed ID: 21554103
[TBL] [Abstract][Full Text] [Related]
70. Use of the chicken lysozyme 5' matrix attachment region to generate high producer CHO cell lines.
Girod PA; Zahn-Zabal M; Mermod N
Biotechnol Bioeng; 2005 Jul; 91(1):1-11. PubMed ID: 15889435
[TBL] [Abstract][Full Text] [Related]
71. A human expression system based on HEK293 for the stable production of recombinant erythropoietin.
Chin CL; Goh JB; Srinivasan H; Liu KI; Gowher A; Shanmugam R; Lim HL; Choo M; Tang WQ; Tan AH; Nguyen-Khuong T; Tan MH; Ng SK
Sci Rep; 2019 Nov; 9(1):16768. PubMed ID: 31727983
[TBL] [Abstract][Full Text] [Related]
72. An enhancer/promoter combination strengthens the expression of blood-coagulation factor VIII in non-viral expression vectors.
Picanço-Castro V; Russo-Carbolante EM; Fontes AM; Fernandes AC; Covas DT
Genet Mol Res; 2008 Apr; 7(2):314-25. PubMed ID: 18551397
[TBL] [Abstract][Full Text] [Related]
73. Tagging and Capturing of Lentiviral Vectors Using Short RNAs.
Panigaj M; Marino MP; Reiser J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638603
[TBL] [Abstract][Full Text] [Related]
74. Comparison of lentiviral vector titration methods.
Geraerts M; Willems S; Baekelandt V; Debyser Z; Gijsbers R
BMC Biotechnol; 2006 Jul; 6():34. PubMed ID: 16836756
[TBL] [Abstract][Full Text] [Related]
75. Assessment of UCOE on Recombinant EPO Production and Expression Stability in Amplified Chinese Hamster Ovary Cells.
Betts Z; Dickson AJ
Mol Biotechnol; 2015 Sep; 57(9):846-58. PubMed ID: 26088164
[TBL] [Abstract][Full Text] [Related]
76. Stable Expression by Lentiviral Transduction of Cells.
Gödecke N; Hauser H; Wirth D
Methods Mol Biol; 2024; 2810():147-159. PubMed ID: 38926278
[TBL] [Abstract][Full Text] [Related]
77. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture.
Broussau S; Jabbour N; Lachapelle G; Durocher Y; Tom R; Transfiguracion J; Gilbert R; Massie B
Mol Ther; 2008 Mar; 16(3):500-7. PubMed ID: 18180776
[TBL] [Abstract][Full Text] [Related]
78. Fluorescence-assisted sequential insertion of transgenes (FASIT): an approach for increasing specific productivity in mammalian cells.
Bravo FE; Parra NC; Camacho F; Acosta J; González A; Toledo JR; Sanchez O
Sci Rep; 2020 Jul; 10(1):12840. PubMed ID: 32732973
[TBL] [Abstract][Full Text] [Related]
79. Quantitative assessment on the cloning efficiencies of lentiviral transfer vectors with a unique clone site.
Zhang G; Tandon A
Sci Rep; 2012; 2():1-8. PubMed ID: 22629482
[TBL] [Abstract][Full Text] [Related]
80. Recombinant protein expression by targeting pre-selected chromosomal loci.
Nehlsen K; Schucht R; da Gama-Norton L; Krömer W; Baer A; Cayli A; Hauser H; Wirth D
BMC Biotechnol; 2009 Dec; 9():100. PubMed ID: 20003421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
